WO2006056874A1 - Forme saline - Google Patents

Forme saline Download PDF

Info

Publication number
WO2006056874A1
WO2006056874A1 PCT/IB2005/003550 IB2005003550W WO2006056874A1 WO 2006056874 A1 WO2006056874 A1 WO 2006056874A1 IB 2005003550 W IB2005003550 W IB 2005003550W WO 2006056874 A1 WO2006056874 A1 WO 2006056874A1
Authority
WO
WIPO (PCT)
Prior art keywords
pain
compound
salt
benzenesulphonate
aminomethyl
Prior art date
Application number
PCT/IB2005/003550
Other languages
English (en)
Inventor
Neil Feeder
Matthew Neil Johnson
Philip Charles Levett
Original Assignee
Pfizer Limited
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0425955A external-priority patent/GB0425955D0/en
Application filed by Pfizer Limited, Pfizer Inc. filed Critical Pfizer Limited
Publication of WO2006056874A1 publication Critical patent/WO2006056874A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne le sel de benzènesulphonate d'acide acétique (1a,3a,5a)--[3-(aminométhyl)bicyclo[3.2.0]hept-3-yle] représenté par la formule structurelle suivante (II). Ce composé est utilisé, en particulier, comme substance médicamenteuse, et est utilisé dans le traitement de la douleur, de l'épilepsie et d'autres états pathologiques.
PCT/IB2005/003550 2004-11-25 2005-11-18 Forme saline WO2006056874A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0425955.2 2004-11-25
GB0425955A GB0425955D0 (en) 2004-11-25 2004-11-25 Salt form
US65776505P 2005-03-01 2005-03-01
US60/657,765 2005-03-01

Publications (1)

Publication Number Publication Date
WO2006056874A1 true WO2006056874A1 (fr) 2006-06-01

Family

ID=35462582

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003550 WO2006056874A1 (fr) 2004-11-25 2005-11-18 Forme saline

Country Status (1)

Country Link
WO (1) WO2006056874A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104334169A (zh) * 2013-04-04 2015-02-04 第一三共株式会社 包含氨基羧酸盐的固体组合物
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
US10603285B2 (en) 2015-03-19 2020-03-31 Daiichi Sankyo Company, Limited Solid preparation including colorant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058680A2 (fr) * 2001-01-26 2002-08-01 Warner-Lambert Company Llc Procede pour prevenir et traiter les douleurs viscerales et les affections gastro-intestinales

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058680A2 (fr) * 2001-01-26 2002-08-01 Warner-Lambert Company Llc Procede pour prevenir et traiter les douleurs viscerales et les affections gastro-intestinales

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104334169A (zh) * 2013-04-04 2015-02-04 第一三共株式会社 包含氨基羧酸盐的固体组合物
US20150079166A1 (en) * 2013-04-04 2015-03-19 Daiichi Sankyo Company, Limited Solid Compositions Comprising a Salt of Aminocarboxylic Acid
KR20150138800A (ko) * 2013-04-04 2015-12-10 다이이찌 산쿄 가부시키가이샤 아미노카르복실산의 염의 고형 조성물
US9675570B2 (en) 2013-04-04 2017-06-13 Daiichi Sanky Company, Limited Solid compositions comprising a salt of aminocarboxylic acid
KR102142257B1 (ko) 2013-04-04 2020-08-07 다이이찌 산쿄 가부시키가이샤 아미노카르복실산의 염의 고형 조성물
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
US10603285B2 (en) 2015-03-19 2020-03-31 Daiichi Sankyo Company, Limited Solid preparation including colorant

Similar Documents

Publication Publication Date Title
US20070191462A1 (en) Combination of A 5-HT(1) Receptor Agonist and an Alpha-2-Delta Ligand for the Treatment of Migraine
EP1861400B1 (fr) Formes cristallines d'un derive d'imidazole
US7649004B2 (en) Pyridine derivatives
US7507742B2 (en) Spirocyclic derivatives
WO2007129188A1 (fr) Composé de cyclopropanecarboxamide
JP2008534567A (ja) Ｖｒ１受容体アンタゴニストとしての置換アリールオキソエチルシクロプロパンカルボキサミド化合物
US20100240652A1 (en) Pyridine Derivatives as Sodium Channel Modulators
US9447066B2 (en) Salts and crystal forms
US20090227680A1 (en) Amino Acid Derivatives
EP1791599A1 (fr) Combinaison d'un agoniste du recepteur 5-ht(1) et d'un ligand alpha-2-delta pour traiter la migraine
WO2006056874A1 (fr) Forme saline
WO2014080633A1 (fr) Formes polymorphes
US20080293746A1 (en) Combinations comprising pregabalin
US20090286875A1 (en) Isocystene derivatives for the treatment of pain
WO2007052134A1 (fr) Acide (2s)-2-aminomethyl-5-ethyl heptanoique et son utilisation pharmaceutique
WO2009136375A1 (fr) Traitement de la cystite interstitielle
WO2007135530A2 (fr) Sel adapté à un usage pharmaceutique et vétérinaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05805841

Country of ref document: EP

Kind code of ref document: A1